Aarti Pharmalabs Ltd.
AARTIPHARM Share PricePharmaceuticals & Drugs
₹881.6
-1 (-0.1%)
As on September 8, 2025
Exchange Scrips: BSE543748NSEAARTIPHARMISININE0LRU01027
Market Cap ₹ 7,978 Cr
P/E Ratio 29.33
Dividend Yield 0.11 %
Performance
Market performance
Open898.85
High901.95
Volumes1,53,132
Prev881.6
Low874.2
As on2025-09-08
Historical performance
1 Year High971
3 Year High971
5 Year High971
1 Year Low557.05
3 Year Low234.8
5 Year Low234.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
7,978
Face Value (₹)
5
P/E Ratio
29.33
Dividend Yield
0.11 %
Investment Returns
1 Year
26.6%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 878.97 | Bullish |
| 10-DMA | 858.91 | Bullish |
| 20-DMA | 844.72 | Bullish |
| 50-DMA | 885.76 | Bearish |
| 100-DMA | 855.69 | Bullish |
| 200-DMA | 767.11 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 48 | 48 | 45 | 46 | 46 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | 47 | 47 | 44 | 45 | 45 |
| Public Investors | 186991 | 196266 | 185066 | 185390 | 188966 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 29.33.
- 3Y Stock Price CAGR of the stock is 74.9.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹4745 Million.
- The company generated revenue of ₹21151 Million in the previous financial year.
Aarti Pharmalabs Ltd.
881.6-1 (-0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1299911.5
No. of Shares: 1474 (Approx)
Performance:30%
P/L: ₹299911.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent